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1. Introduction 
Significant survival of cryopreserved cells became a reality only after the discovery and the 
use of cell-membrane-permeating cryoprotective agents (CPAs) (e.g. glycerol, Polge et al, 
1949). Before freezing, one or various CPAs should be added to cell suspensions to prevent 
the cells from the cryoinjury during the freezing and thawing processes. Unfortunately, the 
CPAs, themselves, may have chemical toxicity to cells after thawing at room temperatures 
(Katkov el al, 1998). Therefore, a post-thaw washing of CPAs is required to remove CPAs 
from cells prior to scientific or medical applications. However, the addition of CPAs to cells 
before freezing and the removal of CPAs from cells after thawing may cause serious cell loss 
and damage if  the processes are not properly handled.  
“One-step” methods were formerly used for addition/removal CPAs. During the “one-
step” CPA addition process, cells are directly (one-step) placed in a solution that is 
hyperosmotic with respect to the permeating CPA but isosmotic with respect to the 
impermeable salts/electrolytes. Cells first shrink because of the osmotic efflux of 
intracellular water and then increase in volume as the CPA permeates and as water 
concomitantly reenters the cells (as shown in Figure 1a). During the “one-step” CPA 
removal process, cells with a high intracellular concentration of CPA are directly exposed to 
an isotonic salt solution without CPA. Cells will swell because of an osmotic influx of 
extracellular water and then decrease in volume as the CPA diffuses out of the cells and as 
water concomitantly moves out (as shown in Figure 1b). As a result of these two aspects (i.e. 
addition and removal of CPAs) of the cryopreservation procedures, the cells may experience 
severe osmotic volume excursion causing significant cell “osmotic” injury (Sherman, 1973; 
Mazur and Schneider, 1984, 1986; Penninckx et al, 1984; Leibo, 1986, Crister et al, 1988a, 
Meryman, 2007). 
Several possible reasons for the osmotic injury have been proposed, including (i) rupture of 
the cell membrane in hypo-osmotic conditions (i.e. expansion lysis); (ii) the water flux 
hypothesis: frictional force between water and potential membrane ‘pores’ caused cell 
membrane damage (Muldrew and McGann, 1994); (iii) the minimum volume hypothesis: 
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cell shrinkage in hyper-osmotic condition is resisted by cytoskeleton components, and the 
resultant interaction between shrunken cell membrane and the cytoskeleton damages the 
cells (Meryman, 1970); (iv) the maximum cell surface hypothesis: the cell shrinkage induces 
irreversible membrane fusion/change, and hence the effective area of cell membrane is 
reduced; when returned to isotonic condition, the cells lyse before their normal volume is 
recovered (Steponkus and Wiest, 1979); and (v) the solute loading hypothesis: hyperosmotic 
stress causes a net leak/influx of non-permeating solutes; when cells are returned to iso-
osmotic conditions, they swell beyond their normal isotonic volume and lyse (Mazur et al., 
1972).  
 
            a          b 
Fig. 1. Cell volume excursion during addition and removal of CPAs 
In order to minimize osmotic injury, many efforts have been made and several techniques 
have been proposed. Basically, people utilize so-called “multi-step methods” instead of 
“one-step method” for addition and removal of CPAs, and the resulting cell recovery rate 
can be significantly improved. During the multi-step CPA addition process, solution with 
high CPA concentration is added into a cell suspension step by step and the CPA 
concentration in the cell suspension increases slowly and gradually. During the multi-step 
CPA removal process, an isotonic salt solution is added into the cell suspension step by step, 
and then by means of centrifugation CPAs in the cell suspension are removed (Figure 2). 
Although to some extend multi-step method reduces osmotic damage of cells, it is complex 
to operate, requires more laboratory staffs, and costs more time, which makes the addition 
and removal procedures more expensive and difficult practically. 
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Fig. 2. Multi-step method for addition and removal of a CPA 
In the past, attempts to develop procedures for the addition and removal of CPAs have been 
made based primarily on empirical approaches, i.e. for a given cell type, various 
temperatures, CPA types and concentrations, and number of procedures or steps for CPA 
addition and removal were empirically tested to find an acceptable procedure. Typical 
techniques includes (i) a multi-step addition and multi-step removal of permeating CPAs 
(Watson, 1979) and (ii) a multi-step addition and two-step removal (using a non-permeating 
solute as osmotic buffer) of CPAs (Rowe et al., 1968; Mazur and Leibo, 1977; Leibo 1981). 
New CPA addition-removal methods and automated devices have recently been developed 
based on fundamental cell membrane transport theory and engineering approaches (Gao, et 
al, 1995; Gilmore et al, 1997; Katkov, 1998;  Myrthe, et al ,2004, Zhou, et al, 2011), which are 
introduced and discussed in this chapter. 
2. Cell membrane transport models and mathematical formulatins 
To date, a number of formalisms exist for describing the cell membrane transport process. 
These include a one-parameter model, a two-parameter model, and a three-parameter 
model, considering solute-solvent interactions.  
i. one-parameter model (Mazur et al, 1974, 1976), 
The one-parameter model utilizes the hydraulic permeability (Lp) of cell membrane as the 
only parameter to describe the water transport across cell membrane. The model can be 
formulized as follows. 
  iwdV
dt
   p c e iL A  (1) 
where, iwV  is the volume of intracellular water, Ac is the area of cell membrane surface, Πe 
and Πi are the extracellular and intracellular osmotic pressures. 
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ii. Two-parameter model 
The two-parameter model was firstly presented by Jacob (1932-1933), and further developed 
by Kleinhans (1998), Katkov (2000) recently. The model utilizes the parameters Lp and Ps 
(CPA solute permeability) to characterize membrane permeability when water, a permeable 
solute and a nonpermeable solute are present: 
  i e iw p cdV L A RT M M
dt
    (2) 
  i e is s c s sdN P A M M
dt
   (3) 
where Ns is the number of osmoles of solute inside cell, R is the universal gas constant, T is 
the absolute temperature, Mi and Me are the intracellular and extracellular osmolality, 
respectively. The subscript ‘s’ refers to permeable solute, and remaining symbols are as 
previously defined.  
iii. Three-parameter model 
The classical formulation of coupled, passive membrane transport was developed by Kedem 
and Katchalshy (1958) using the theory of linear irreversible thermodynamics. The 
formulation includes two coupled first-order non-linear ordinary equations which describe 
the total transmembrane volume flux and the transmembrane permeable solute flux 
respectively. 
In the model (so called Kedem-Katchalssky transport formalism or KK formalism), a 
reflection coefficient (σ) was introduced with Lp and Ps to describe water and solute (CPA) 
transport across the plasma membrane: 
    e i e ic p c n n s sdV L A RT M M M M
dt
        (4) 
    1i e is cs s c s sdN dVM P A M M
dt dt
     (5) 
Where Vc is cell volume, sM is the average osmolality of intracellular and extracellular 
solution, and the subscript ‘n’ refers to nonpermeable solute, respectively.  
The KK formalism used to be the most general of the three mentioned. However, more 
recent literature suggests that aquaporins in cell membrane are highly selective, with 
nonionic solute transport occurring mainly through the lipid bilayer or through other 
channels that are distinct from the aquaporins (Gilmore et al, 1995; Preston et al, 1992). In 
this case, the estimation of σ as independent parameter may be inappropriate and may not 
be relevant from a biological stand point (Kleinhans, 1998). By assuming that there is no 
interaction between water and solute during their transport through the membrane, the 
value of σ can be determined as    1 s s pPV RTL , where sV = partial molar volume of 
permeating solute. In this manner, the KK formalism can still get correct result as two 
parameter model.  
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In the following context, two examples are demonstrated to show how to use cell membrane 
transport models and mathematical formulations to develop optimal conditions and 
technology/instrument for the addition and/or removal of the permeating CPAs in cells. 
An important hypothesis is that the degree of cell volume excursion can be used as an 
independent indicator to evaluate and predict the possible osmotic injury of the cells during 
addition and removal of CPAs. 
Example 1: Development of optimal “multi-step methods” for addition and dilution of 
glycerol in human sperm 
Glycerol is the most commonly used CPA in the cryopreservation of spermatozoa (Polge et 
al, 1949; Watson, 1979; Critser etl al., 1988a). Glycerol permeability characteristics for human 
spermatozoa have been very well studied and reported (Du et al, 1994; Gao et al., 1992). The 
hypothesis above was tested first using the following procedures: (i) to determine sperm 
osmotic injury as a function of its volume excursion limits (swelling/shrinking) in 
anisosmotic solutions containing only non-permeating solutes without glycerol; (ii) to 
simulate, by computer, the kinetics of water-glycerol transport through the sperm plasma 
membrane and to calculate the sperm volume excursion during different glycerol addition 
and removal processes using membrane transport equations and previously determined 
sperm membrane permeability coefficients for glycerol and water; (ii) combining 
information obtained from procedures (i) and (ii), to predict sperm osmotic injury caused by 
different procedures of glycerol addition and removal; and (iv) to perform experiments to 
test the predictions. If the hypothesis is confirmed, the above procedures also provide a 
methodology for predicting optimal protocols to reduce the osmotic injury associated with 
the addition and removal of high concentrations of glycerol in human spermatozoa. 
2.1 Materials and methods 
Preparation of sperm suspension 
Human semen samples were obtained by masturbation from healthy donors after at least 2 
days of sexual abstinence. Samples were allowed to liquefy in an incubator (5% CO2, 95% 
air, 37C, and high humidity) for ~1h. A total of 5 ul of the liquefied semen were used for a 
computer-assisted semen analysis (CASA) using CellSoft (Version 3.2/C, CRYO Resources, 
Ltd, Montgomery, NY, USA) (Jequier and Crich, 1986; Crister et al., 1988b). A swim-up 
procedure was performed to separate motile form immotile cells [layering 500ul of modified 
Tyrode’s medium (TALP: Bavister et al., 1983) over 250 ul of semen, incubating for ~1 h in 
the incubator and carefully aspirating 400 ul of the supernatant in which >95% of 
spermatozoa were motile]. The motile cell suspensions were centrifuged at 400g for 7min 
and resuspended in the TALP medium (286~290 Osmol) supplemented with pyruvate (0.01 
mg/ml) and bovine serum albumin (4 mg/ml), at a cell concentration of 1×109 cell/ml. 
Assessment of human sperm membrane integrity 
A methodology for the assessment of sperm membrane integrity, using dual florescent 
staining and flow cytometric analysis, has been developed by Garner et al. (1986) and 
previously validated in our laboratory (Gao et al., 1992, 1993; Noilles et al., 1993). Propidium 
iodide (catalogue no. P4170; Sigma Chemical Co., St Louis MO, USA) is a bright red, nucleic 
acid-specific fluorophore which permeates poorly into spermatozoa with intact plasma 
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membrane, but is able to diffuse readily in to spermatozoa with a damaged membrane. 6-
Carboxyfluoroscein diacetate (CFDA; Sigma, Catalog #C5041) is a membrane- permeable 
compound. After penetrating into cells, it is hydrolysed by intracellular esterase to 6-
carboxyfluoroscein which is a bright green, membrane-impermeable fluorophore (Garner et 
al., 1986). When CFDA is added into the cell suspension with membrane-intact 
spermatozoa, the cells fluoresce bright green (Garner et al., 1986). Thus 5 ul CFDA (0.25 
mg/ml DMSO) and 5 up propidium iodide (1 mg/ml water) stock solutions were added to 
each o.5ml of the treated sperm suspensions. A total of 1×105 spermatozoa per treatment 
were analyzed using a FACStar Plus Flow cytometer (Becton Dickinson, Rutherford, NJ, 
USA). The cells with CFDA staining and without propidium iodide staining were 
considered as intact cells. The percentage of intact cells was determined for each treatment. 
The flow cytometer settings used for the experiments were (i) the gates were set using 
forward and 90° light scatter signals at acquisition to exclude debris and aggregates; (ii) 
instrument alignment was performed daily with fluorescent microbead standards to 
standardize sensitivity and setup; (iii) photomultiplier settings were adjusted with 
unstained overlap with individually stained cells; (iv) excitation was at 488 nm from a 4 W 
argon laser operating at 200 mW. Fluorescein emission intensity was measured using a 
530/30 nm bandpass filter, and propidium iodide intensity using a 630/22 m bandpass 
filter. 
Determination of osmotic injury as a function of sperm volume excursion in anisosmotic 
solutions of nonpermeating solutes 
The anisosmotic solutions, ranging from 40 to 1500 mOsmol, were prepared as follows: 
hypo-osmotic solutions were made osmotic solutions were made by adding sucrose to 
TALP medium (sucrose and the solutes in TALP medium are essentially membrane-
impermeable compounds). The final osmolality of each solution was measured and checked 
using a freezing-point depression osmometer (Adanced DigiMate Osmometer, Model 3D2; 
Advanced Instrument, Inc., Needham Heights, MA, USA). The osmotic tolerance of human 
spermatozoa was evaluated by exposing the cells to the anisosmotic solutions. A 10ul 
volume of isotonic cell suspension (286 mOsmol, 1×109 cells/ml) was mixed with 150μl of 
each anisosmotic solution. After 1 s to 30 min, spermatozoa in each anisosmotic solution 
were returned to near isotonic conditions (272-343 mOsmol) by adding 1500 μl isotonic 
TALP medium to 100 μl of each anisosmotic cell suspension. Sperm motility and plasma 
membrane integrity were measured by CASA and CFDA-propidium iodide dual fluorescent 
staining techniques respectively before and after the anisosmotic exposure. The centrifugal 
force used in sample preparation was 400 g for 7 min. All experiments were conducted at 
22°C. 
Thermodynamic modeling and mathematical formulation for glycerol and water 
permeating across the human sperm membrane 
The next step was to compute the osmotic cell volume excursions associated with the 
addition and removal of hyperosmotic solutions of the permeating cryoprotectant glycerol 
to suspensions of human spermatozoa in isotonic saline. The classical KK formalism (shown 
as equations (4) and (5)) is used here and for the case of a solution consisting of a single 
permeable solute (e.g. glycerol) the average of extracellular and intracellular cryoprotective 
agent concentrations (osmolality) can be given as 
www.intechopen.com
Prevention of Lethal Osmotic Injury to Cells  
During Addition and Removal of Cryoprotective Agents: Theory and Technology 
 
107 
   lne i e is s s s sM M M M M      
Since human spermatozoa behave as ideal osmometer (Du et al., 1993), intracellular 
concentrations of impermeable solute (salt) and permeable solute (cryoprotective agent) can 
be calculated as previously described (Mazur and Schneider, 1984). 
           
0 0
0
i
b s si i
n n i
b s s
V V V N
M t M
V t V V N t
       
 (6) 
       
i
si
s i
b s s
N t
M t
V t V V N t
      
 (7) 
Where Vb= osmotically inactive cell volume (um3), and 0=initial condition (t=0). Initial 
conditions for V(0),  0inM ,  0isM ,  0isN are known based on each experimental condition 
or protocol. In the computer simulations, it was assumed that extracellular concentrations of 
permeating or non-permeating solutes were constant, and that the mixture of solutions during 
the glycerol addition and removal was instantaneous, i.e. the mixing time =0. 
Human sperm volume, surface area, vb, water and glycerol permeability coefficients have 
been determined and previously published (Gao et al., 1992; Kleinhans et al., 1992; Noiles et 
al., 1993; Du et al., 1994). The values of these parameters are shown in Table 1. Assuming 
that there is no interaction between water and glycerol during their transport through the 
sperm membrane (or in other words, water and glycerol penetrate the cell membrane 
independently), the value of    1 s s pPV RTL    (Kedem and Katchalsky, 1958), can be 
calculated. From this equation and the data in Table 1, σ was calculated to be 0.99. This 
value was used in the present example. 
 
Surface area (A) 120μm2 Kleinhans et al (1992) 
Volume (V) 34μm3 (Kleinhans et al. (1992) 
Osmotically inactive volume (Vb) 16.6μm3 Kleinhans et al. (1992) 
Du et al. (1993) 
Water permeability coefficient (Lp) 2.4μm/min/atm Noiles et al. (1993) 
Glycerol permeability coefficient (Ps) 1.68×10-3cm/min Gao et al. (1993) 
Table 1. Characteristic of human spermatozoa at 22°C 
Using equations [4-7] kinetics of glycerol/water transport across the sperm plasma 
membrane as well as the cell volume excursion during different glycerol addition and 
removal procedures were calculated using a commercial differential equation solver, SLAB 
(Civilized Software, Inc., Bethesda, MD, USA). The sperm volume excursion and water 
transport through the membrane of cells in anisosmotic solution without glycerol were 
calculated using equation [4] and [5] with Ms=0 and Ns=0. 
Addition of glycerol 
A final 1.00 M glycerol in sperm suspension was achieved by 1:1 (v/v) mixing of the 
original, isotonic sperm suspension with 2.0M glycerol solution which contains an isotonic 
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(non –permeating solute) salt concentration. Two approaches for mixing the 2.0 M glycerol 
solution with the sperm suspension were used, i.e. a fixed-volume-step (FVS) approach and 
a fixed –molarity-step (FMS) approach: 
Approach 1: fixed-volume-step addition 
A 2.0 M glycerol solution was added stepwise to the sperm suspension, and the volume of 
the 2.0 M glycerol solution added in each step was constant. For example, to make a four 
step addition of 1ml of 2.0 M glycerol solution to a 1 ml isotonic sperm sample, 0.25 ml of 2.0 
M glycerol solution would be added four times to the isotonic sperm suspension. The time 
interval between any two steps was 0.5-1 min. 
In the general case, the volume of cryoprotective agent stock medium added to cell 
suspension in each step can be calculated by the following equation: 
 
1f o
i
o f
M V
V
M M n
   (8) 
Where Mf= the final CPA concentration (molarity) in the cell suspension, Mo = 
cryoprotective agent concentration (molarity) in the original stock cryoprotective agent 
medium, n= total number of steps, i=ith step addition, Vo= the original volume of isotonic 
cell suspension, and Vi= the volume of CPA stock medium added into cell suspension at the 
ith step. 
Approach 2: fixed-molarity-step addition 
Glycerol-containing medium was added stepwise into the cell suspension in such a way that 
the glycerol molar concentration in the cell suspension was increased by a fixed amount 
after each step of addition. For example, to increase the molarity by 0.25 M in each of four 
steps, 0.14, 0.19, 0.27 and 0.4 ml of 2.0 M glycerol stock solution should be added (step by 
step, four steps in total) to 1 ml of the sperm suspension. The time interval between any two 
steps was 0.5-1min. 
In the general case, the volume of cryoprotective agent stock medium added to cell 
suspension at the ith step can be calculated by the following equation: 
    1)f o oi o f o f
M V n M
V
nM iM nM i M
       
  where i=1, …, n (9) 
   * 1* 1
1
1
i i
o i
V V
n V V 
   (10) 
 * 1i o kV V V     where k=1, …, i-1 (11) 
 o
f
M
M
   (12) 
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fM
M
n
   (13) 
Where Mf = the final cryoprotective agent concentration in the cell suspension (molarity), 
Mo = cryoprotective agent concentration in the original stock cryoprotective agent medium 
(molarity), n= total number of steps, i =ith-step addition, Vo= the original volume of isotonic 
cell suspension (ml), ∆M= increment of glycerol molarity in cell suspension after each step 
of glycerol addition, * 1iV   = the total volume of cell suspension before the ith-step addition, 
Vi= volume of cryoprotective agent stock medium added to cell suspension at the ith step. 
Removal of glycerol 
To dilute the concentrated glycerol in the sperm suspension and remove glycerol from the 
cells, an isotonic without glycerol was added stepwise to the suspension. The FVS approach, 
FMS approach, and a two-step osmotic buffer approach were used for the dilution. 
Approach 1: FVS dilution 
Given the volume of the sperm suspension (Vo) with an initial cryoprotective agent 
concentration (Mo), the total volume of isotonic solution required to dilute the cryoprotective 
agent concentration from Mo to Ms can be calculated by the following equation: 
 1o
s
M
V
M
    
 (14) 
Using the FVS approach, the volume of isotonic solution which needs to be added to be cell 
suspension at the ith-step during the first n-1 steps (n steps in total) can be calculated as 
follows: 
 1
1 1
o o
i
s
V MV
V
n n M
       
 (15) 
where Ms = cryoprotective agent concentration in the cell suspension (molarity) after n-1 
step dilutions, Mo =cryoprotective agent concentration initial sperm suspension (molarity), 
n= total number of steps, i=the ith-step addition, Vo= original volume of cell suspension (ml) 
and Vi= volume of isotonic solution added into cell suspension at the ith step. After n-1 steps 
of addition of isotonic solution into the cell suspension, the diluted sperm suspension was 
centrifuged (400 g for 5-7 min), and then the sperm pellet was resuspended in an isotonic 
solution, which results in the last (nth) step removal of glycerol from the cells. 
Approach 2: FMS dilution 
Concentrated glycerol in the sperm suspension was diluted stepwise by addition of an isotonic 
solution. The decrement in the molarity of glycerol after each step dilution was fixed. In the 
general case, the following equation can be used to calculate the volume of isotonic solution 
added to cell suspension at the ith step during the first n-1 step (n steps in total): 
 o
M
M
n
   (16) 
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   * 1* 1
1
1
i i
o i
V V
n V V


    where i=1, …, n-1 (17) 
 * 1i o kV V V     where k=1, …, i-1 (18) 
where ∆M= the decrement in the glycerol molarity in the spermatozoa after each stepwise 
addition of the isotonic solution, Mo = cryoprotective agent concentration (molarity) in the 
initial sperm suspension, n= total number of steps, i=ith-step addition, Vo=original volume of 
cell suspension, * 1iV  = the total volume of cell suspension before the ith-step addition and 
Vi= volume of isotonic solution added into cell suspension at ith step. After n-1 step of 
addition , the cryoprotective agent concentration in the cell was diluted to ∆M. Then 
spermatozoa were transferred to isotonic conditions, which is the last (the nth) step removal 
of glycerol, see Table 2 fore examples. 
Approach 3: Two-step dilution with an osmotic buffer 
 
Eight-step dilution 
Fixed-volume-step method Fixed-molarity-step method 
Add 100 μl of isotonic TALP seven times 
to 100 μl of sperm suspension to achieve 
a final glycerol concentration of 0.125 M. 
After centrifugation, 710 μl of 
supernatant is taken off. The remaining 
cell suspension is 90 μl 
(1) Stepwise add 14.3, 19, 26.6 and 40 μl of 
isotonic TALP medium to 100 μl of sperm 
suspension with 1.0 M glycerol; (2) centrifuge 
the supernatant; stepwise volume add 10, 20 
and 60 μl of isotonic solution to the remaining 
30 μl of sperm suspension. After the seven 
dilution steps, the glycerol concentration in 
the sperm suspension is 0.125 M. The final 
suspension volume is 120 μl. 
The final sperm suspensions (90 or 120 μl) were further diluted by adding 180 μl of TALP 
solution. The time interval between any two steps was ~0.5-1 min. The volume of diluent 
added in each step was calculated using equation [8] or [9] 
One-step dilution  
Add 2000 μl of isotonic solution directly to 100 μl of cell suspension with 1.0 M glycerol 
Table 2. Procedures used in one-step and eight-step removal of 1.0 M glycerol from human 
spermatozoa 
1. Add 2000 μl of sucrose buffer medium (TALP + sucrose, 600 mOsm to 100 μl of 
sperm suspension with 1.0 M glycerol. (The total length of time spermatozoa 
were in contract with sucrose was 0.5 min before centrifugation. 
 Centrifuge the suspension (400 g for 7 min) and aspirate the supernatant. 
 Resuspend the cell pellet with 500 μl of isotonic TALP medium 
Table 3. Procedures used in the two-step removal of 1.0 M glycerol from spermatozoa using 
sucrose as an osmotic buffer 
In the first step, glycerol was directly removed by transferring cells to a hyperosmotic 
medium (osmotic buffer, TALP with sucrose) containing no glycerol but only non-
permeating solutes (salts and sucrose), and in the second step spermatozoa in the osmotic 
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buffer were directly transferred to an isotonic solution (TALP), (Table 3) (Rowe et al, 1968; 
Mazur and Leibo, 1977; Leibo, 1981). 
Experimental examination of the predicted osmotic injury during addition /removal of 
glycerol 
Medium (TALP) with 2.0M glycerol was added either in one step or stepwise (using FVS or 
FMS approaches) to an equal volume of the isotonic sperm suspension to achieve a final 1.0 
M glycerol concentration at 22°C. The glycerol in the spermatozoa was removed/diluted by 
a one-step or stepwise addition (using FVS or FMS approaches) of TALP medium, with or 
without an osmotic buffer (sucrose), to the cell suspension. Some detailed procedures for the 
removal of glycerol are described in Table 2 and 3. Sperm motility and plasma membrane 
integrity were measured before and after the different glycerol addition and removal 
procedures by CASA and the dual staining technique and flow cytometry respectively. 
Statistical analysis 
Data were analyzed using standard analysis of variance approaches with the General Linear 
Models procedure of the Statistical Analysis System (Spector et al., 1985). Comparisons were 
conducted using a protected LSD (least significant difference) approach (Zar, 1984). 
2.2 Result 
The percentage of spermatozoa which maintained motility or plasma membrane integrity 
after each treatment was normalized to that of untreated, isotonic control samples and the 
data are so presented. 
Determination of osmotic injury as a function of sperm volume excursion 
Human spermatozoa were exposed for 5min to hyper- or hypo-osmotic solutions of sucrose 
and TALP salts ranging in concentration from 60 to 1200 mOsmol, and their motilities were 
then determined by CASA while still in those solutions. Figure 3 shows that sperm 
motilities dropped significantly when the osmolality was >50 mOsmol above or below 
isotonic (286 mOsmol). Motilities approached zero when the osmolalities were <200 or >600 
mOsmol. 
The next step was to compare these motilities with those observed after spermatozoa were 
transferred from these anisosmotic solutions back to near isotonic solutions. Figures 4 and 5 
show the motilities as a function of time after transfer from hyperosmotic or from hypo-
osmotic exposures respectively. In both cases, the more the initial exposure departed from 
isotonicity, the greater the damage upon return to isotonicty. Most, or all, of the damage was 
evident in the first 30 s after the return, although in the case of transfer from hypertonic 
solutions to near isotonic, there was a further slight and gradual decline over the ensuing 30 
min. 
Figure 6 compares sperm motilities after a 5 min exposure to the various anisosmotic 
solutions before and after the return to near isotonic conditions. The reduction in the 
motilities of spermatozoa exposed to hypo-osmotic media was not affected by the return to 
isotonic media, but most of the apparent loss of motility of spermatozoa in hyperosmotic 
media of between 286 and 600 mOsmol was reversed when spermatozoa were returned to 
near isotonic. For example, although only 10% of spermatozoa were motile in 600 mOsmol  
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Fig. 3. Percent motility (mean±SEM, n=8) of human spermatozoa which were abruptly (one-
step) exposed to different osmotic conditions for 5 min at 22°C. 
 
 
Fig. 4. Percent motility (mean±SEM, n=8) of human spermatozoa which were abruptly (one-
step) returned to near isotonic conditions (305-343 mOsmol) after they had been exposed to 
different hyperosmotic conditions (TALP +sucrose) for different periods of time. ˒, 600 
mOsmol; ˑ, 700 mOsmol;○, 900 mOsmol; ●, 1200 mOsmol. 
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Fig. 5. Percent motility (mean±SEM, n=8) of human spermatozoa which were abruptly (one-
step) returned to near isotonic conditions (273-284 mOsmol) after they had been exposed to 
different hyperosmotic conditions (TALP +water) for different periods of time. ˍ, 240 
mOsmol; ○, 215 mOsmol;●, 190 mOsmol; ˒,143 mOsmol; ˑ, 114 mOsmol; ˎ, 90 mOsmol. 
 
Fig. 6. A comparison of human sperm motility (% mean±SEM, n=8) after a 5 min exposure to 
the various hypo- and hyperosmotic solutions of non-permeating solutions before (○) and 
after (ˎ) the return to near isotonic conditions (273-343 mOsmol). 
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Fig. 7. Membrane integrity (CFDA and propidium iodide stain) (% mean±SEM, n=8) of 
human spermatozoa which were abruptly (one-step) returned to near isotonic conditions 
(273-343 mOsmol) after they had been exposed to different anisosmotic conditions for 5 min. 
solutions, 95% of spermatozoa were motile after return to isotonic media. The return to near 
isotonic became especially damaging, however, when the initial hyperosmotic concentration 
was >600 mOsmol. 
Figure 7 shows that integrity of the plasma membrane of spermatozoa (as assessed by 
CFDA /propidium iodide) was substantially more resistant to wide excursions from 
isotonicity than was motility. Thus, >90% of those spermatozoa exposed to a 90 mOsmol salt 
solution retained intact plasma membrane after return to near isotonic, whereas <10% 
remained motile both before and after return to isotonic. Loss of plasma membrane integrity 
in 50% of the spermatozoa occurred only when spermatozoa were exposed to a 60 mOsmol 
solution, a figure that agrees with a previous report (Noiles et al, 1993); that loss occurs 
whether or not spermatozoa are returned to isotonic. This has been interpreted to represent 
lysis from the attainment of a cell volume in excess of that tolerated by the surface area of 
the plasma membrane. 
Using light microscopy, morphological changes in sperm cells were observed during the 
exposure to anisosmotic solutions. In a portion of the spermatozoa, the tail region became 
configured as a ‘zigzag’ pattern when exposed to a hyper-osmotic solution. The pattern of 
sperm tail curling in hypo-osmotic solutions was osmolality dependent, which is consistent 
with a previous report (Jeyendran et al., 1984). In addition, the curling of sperm tails 
occurred not only when the isotonic spermatozoa were exposed to a relative hypo-osmotic 
condition. (For example, the shrunken spermatozoa in hyperosmotic solutions were 
returned to iso-osmotic conditions. Iso-osmolality was ‘hypo’ relative to a given hyper 
osmolality.) The tail curling was irreversible. The mechanism(s) behind the morphological 
change is not clearly understood. 
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Calculated volume excursions associated with exposures to anisosmotic solutions 
Since it has been shown that human spermatozoa behave as ideal osmometer over most of 
the range of osmolalities studied here (Du et al., 1993), a direct physical consequence of the 
exposures to anisosmotic conditions is major excursion in cell volume. The kinetics of 
volume excursion of spermatozoa in these hypo- and hyperosmotic solutions (containing 
only non-permeating solutes) were calculated and are plotted in Figure 8A and B  
   
 
Fig. 8. (A) Calculated relative sperm volume (normalized to an isotonic sperm volume of 1) 
as a function of time after spermatozoa were one-step exposed to different hypo-osmotic 
solution containing non-permeating solutes. (B) Calculated relative sperm volume 
(normalized to the isotonic sperm volume of 1) as a function of time after the isotonic 
spermatozoa were one-step exposed to different hyperosmotic solutions containing non-
permeating solutes. 
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respectively, indicating that only a short time was required for human spermatozoa to 
achieve osmotic equilibration (<1 s for shrinking, and ≤30 s for swelling). Figure 8A and B 
also show the maximum or minimum volume of spermatozoa when they were osmotically 
equilibrated with each anisosmotic solution. Sperm equilibration volume as a function of 
extracellular osmolality is shown in Figure 9, which can be calculated using equation (6) (no 
cryoprotective agent) or obtained directly from Figure 8A and B. To obtain a high (>95%) 
motility recovery, the lowest and highest osmolalities which human spermatozoa can 
tolerate (Figures 4 and 5) were found to be close to 240 and 600 mOsmol respectively. At 
these two osmolalities, the corresponding cell volume at osmotic equilibrium were directly 
estimated (Figure 9) to be ~1.1 (for 240 mOsmol) and 0.75 (for 600 mOsmol) times the 
isotonic sperm volume, indicating that spermatozoa can only swell or shrink in a relatively 
narrow range to maintain high post-anisosmotic motility recovery. Based on Figure 4, 5 and 
9, Figure 10 was plotted, which clearly shows the post-anisosmotic injury (motility loss) as a 
function of osmotic equilibrium volume of spermatozoa in anisosmotic solutions. Defining 
lower volume limit (LVL) and upper volume limit (UVL) as cell volumes at which 5% of 
motile spermatozoa may irreversibly lose their motility, or, reciprocally, 95% of 
spermatozoa maintain their motility, one can obtain the LVL and UVL values for human 
spermatozoa from Figure 10 as follows: LVL =0.75×isotonic sperm volume, UVL=1.10× 
isotonic sperm volume. 
Prediction of optimal protocols for glycerol addition/removal 
The kinetics of human sperm volume excursion during one-step addition and removal of 
0.5-2.0 M glycerol were calculated using equations (6-9) and are shown in Figure 11A and B 
respectively. The higher the glycerol concentration, the longer the time period taken for 
sperm volume recovery and the greater the volume excursion.  
Two different approaches, i.e. fixed-volume-step (FVS) and fixed-molarity-step (FMS), for 
the addition/removal of glycerol in spermatozoa were considered and used in the present 
example. Based equations (6-9), the kinetics of water and glycerol transport through the  
 
Fig. 9. Calculated relative sperm volume (normalized to the isotonic sperm volume of 1) 
after spermatozoa were osmotically equilibrated to different anisosmotic conditions. 
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Fig. 10. Post-anisosmotic sperm motility recovery as a function of relative sperm volume 
(normalized to the isotonic sperm volume of 1) in different anisosmotic equilibrium states. 
Human spermatozoa were abruptly (one-step) returned to near isotonic conditions after 
exposure to anisosmotic conditions for 1 min. 
sperm membrane were simulated by computer. Figure 12 shows the calculated sperm 
volume excursion during a one—step or four-step addition of glycerol achieve a final 1.0 M 
glycerol concentration at 22 C using the FMS and FVS approaches respectively. From Figure 
12, a one-step addition of glycerol to spermatozoa was predicted to cause ~20% sperm 
motility loss because the minimum volume which the cells would achieve during this 
glycerol addition was ~72% of the cells would achieve during this glycerol addition was 
~72% of the original cell volume, i.e. below the LVL (75% or 0.75 ×isotonic sperm volume). 
In contrast, a four-step FMS glycerol addition was predicted to be able to prevent sperm loss 
(<5% loss). Figure 12 also shows a comparison between a four-step FVS and FMS approach. 
A four-step FVS method was predicted to cause a lower minimum volume than a four-step 
FMS method. From Figure 13, a one-step removal of 1.0 M glycerol was predicted to cause 
>70% motility loss, because the maximum cell volume during the glycerol removal was 
calculated to be in excess of 1.6 times the isotonic cell volume, which is much higher than the 
UVL (1.1×isotonic sperm volume). Figure 14 shows that a four- or six-step FMS removal 
procedure was predicted to reduce sperm motility loss significantly, but these still may cause 
>*5 % motility loss, while an eight-step FMS removal was predicted to able to prevent sperm 
motility loss (<5% loss). Figure 13 also shows a comparison between an eight-step FMS and an 
eight-step FVS removal procedure. An eight-step FVS removal was predicted to cause a 
maximum cell swelling >1.2* isotonic cell volume (>UVL), while the maximum cell volume 
during an eight-step FMS removal was predicted to be much lower than the UVL, indicating 
the eight-step FVS removal is not as good as an eight-step FMS. Based on the data presented  
in Figures 11-14, it was also found, from calculations, that human spermatozoa will  
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Fig. 11. (A) Calculated relative sperm volume (normalized to the isotonic sperm volume of 
1) as a function of time after the isotonic sperm were exposed to different hyperosmotic 
glycerol solution isotonic with respect to non-permeating solutes (salt). (B) Calculated 
relative sperm volume (normalized to the isotonic sperm volume of 1) as a function of time 
after spermatozoa, which had been pre-equilibrated with different hyperosmotic glycerol 
solutions isotonic with respect to non-permeating solutes (salt), were one-step exposed to 
isotonic (286 mOsmol) saline solution without glycerol. 
 
Fig. 12. (left) Calculated relative sperm volume (normalized to the isotonic sperm volume of 1) 
as a function of time after 1M glycerol was added to spermatozoa by either one-step or four 
fixed molarity steps. (right) Calculated relative sperm volume (normalized to the isotonic 
sperm volume of 1) as a function of time 1M glycerol was added to spermatozoa by either one 
step or four fixed-volume steps. The estimates of percent motility recovery as a function of 
sperm relative volume were obtained from Figure 8 and are indicated in the diagrams. 
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Fig. 13. Calculated relative sperm volume (normalized to the isotonic sperm volume of 1) as 
a function of time after 1 M glycerol was removed from spermatozoa by one-step, eight 
fixed-molarity steps or eight fixed-volume steps. The estimates of percent motility recovery 
as a function of sperm relative volume were obtained from Figure 10 and are indicated in 
the diagrams. 
rapidly achieve an osmotic equilibrium (within 15 s) during any stepwise addition or 
removal of glycerol. For example, from the calculations, human spermatozoa achieve 
osmotic equilibrium within 15 s after each step addition of glycerol by either one-step of 
four-step addition (Figure 12). This indicates that only a short time interval between steps of 
glycerol addition/removal is required for cells to achieve corresponding osmotic 
equilibration volume after each step of glycerol addition and removal. 
In the analysis above, sperm osmotic injury (motility loss) caused by different glycerol 
addition/removal procedures has been predicted and a four-step FMS addition and an 
eight-step FMS removal of 1.0 M glycerol were found to be acceptable protocols to prevent 
sperm motility loss (<5%). 
Theoretical evaluation of two-step glycerol removal using an osmotic buffer 
A two-step removal of cryoprotective agent from human spermatozoa using a non-
permeating solute as an osmotic buffer has been previously used to avoid osmotic injury in 
other cell types (Rowe et al., 1968; Leibo and Mazur, 1978; Watson, 1979). The steps involved 
in this approach are (i) the cryoprotective agent is directly removed and cell swelling is 
reduced by transferring cells with the cryoprotective agent to a hyperosmotic medium 
(osmotic buffer) of non-permeating solutes; and (ii) the cells in the osmotic buffer are 
rehydrated by directly transferring them to isotonic solution. Since current results showed 
that 600 mOsmol was the hyperosmotic upper tolerance limit for human spermatozoa to 
maintain 95% motility, the osmolality of the osmotic buffer medium should not exceed 600 
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mOsmol. Using this liming criterion, a hyperosmolality of 600 mOsmol would be expected 
to provide the maximum ‘buffer effect’ to reduce sperm volume swelling during the first 
step of glycerol removal. Sperm volume excursion during this two-step glycerol removal 
process was calculated and is shown in Figure 15. It was predicted that the maximum 
volume spermatozoa would achieve is 1.25 times (15%) the isotonic cell volume, which is 
higher than the UVL of human spermatozoa, and could be expected to cause >40% sperm 
motility loss, as predicted from Figure 10. 
 
Fig. 14. Calculated relative sperm volume (normalized to the isotonic sperm volume of 1) as 
a function of time after 1 M glycerol was removed from spermatozoa by four, six and eight 
fixed-molarity steps. The dotted lines in this figure indicate the upper volume limit, 1.1, 
below which >95% of spermatozoa can maintain the motility. The four- or six-step dilution 
results in a cell volume excursion causing >5% motility loss. 
Results from experimental examination 
Glycerol was added to or removed from human spermatozoa using stepwise procedure to 
test the theoretical predictions. A one-step addition resulted in ~19.2% sperm motility loss 
or 81.8±8.7% ( SEMX , n=15) motility recovery, while the four-step FMS or FVS addition 
significantly (P<0.001) increased in the motility recovery to 93.5±5.6% ( SEMX , n=15) or 
91±4.8% ( SEMX , n=15) respectively. During different glycerol removal procedures (c.f. 
Table 2), <30% (28.5±3.8%, n=15) of motile spermatozoa kept their motility after a one-step 
removal of 1.0 M glycerol, while the majority of spermatozoa (92±8.2%, n=15) maintained 
motility after the eight-step FMS removal. In comparison, only 62±5.8% of spermatozoa 
maintained motility after eight-step FVS removal. The motility recovery after a two-step 
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removal of glycerol (Table 3) using sucrose as an osmotic buffer was 43±5.3% ( SEMX , 
n=15). The experimental result agreed well with the predictions generated from the 
computer simulations. Data analyses indicated that the different glycerol removal 
procedures caused different motility losses (P<0.001 between any two procedures). Over 
90% of spermatozoa maintained membrane integrity under all experimental conditions. 
 
Fig. 15. Calculated relative sperm volume (normalized to the isotonic sperm volume of 1) as 
a function of time after 1 M glycerol was removed from spermatozoa by two steps using a 
‘hyperosmotic buffer’ solution. Step 1: 1.0 M glycerol was removed from spermatozoa by 
one -step exposure of spermatozoa to 600 mOsmol hyperosmotic (salt+sucrose) solution 
without glycerol. Step 2: Spermatozoa in the 600 mOsmol solution were returned to isotonic 
condition (286 mOsmol) in one step. 
Example 2: Development of a novel dilution-filtration method and instrument to remove 
glycerol from human red blood cells (RBCs) 
Cryopreservation has been widely used today around the world for long term preservation 
of RBCs. In the USA, the FDA has approved the storage of frozen RBCs at -80°C for as long 
as 10 years (Meryman, 2007). However, the glycerol in RBCs must be reduced to final 
concentration below 1% before infusion to prevent hemolysis (Valeri et al, 2001). The step of 
removing CPAs may cause serious cell loss due to the cell volume excursion induced by 
osmotic disequilibria (Meryman, 2007). In the past decades, many efforts have been made to 
improve the process (Rowe et al, 1968; Meryman et al, 1972, 1977; Valeri et al, 1975, 2001; 
Castino et al,1996; Arnaud et al 2003). 
Currently, multi-step centrifuging methods are most commonly used, and some of them can 
achieve favorable results (Rowe et al, 1968; Meryman et al, 1972, 1977; Valeri et al, 1975, 
2001). However, the procedures are very difficult and time consuming for manual operation 
due to the large cell suspension volume or high CPA concentration. In addition, most of the 
systems are not closed and are thus open to contamination (Castino et al,1996; Valeri et al, 
2006). Automatic centrifuging systems may significantly reduce human labor and 
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contamination (Valeri et al, 2001), but the expensive cost limits their application in many 
areas. Recently, Dialysis was considered as an alternative method by some researchers 
(Castino et al,1996; Arnaud et al 2003; Ding et al 2007,2010). It can remove CPAs efficiently; 
however, due to the non-uniformity of distribution of hollow fibers, the mass transport in 
dialyzer is too complicated to be controlled, especially in the unsteady state. In addition, 
dialysis method is not efficient to remove large molecular substances (Daugirdas, et al, 
2006), such as cell fragment and the released protein from broken cells. These factors limit 
the use of dialysis method in some applications. 
In clinic, hemofiltration, which involves dilution and filtration to remove toxins from blood, 
has been proved to have better controllability as well as ability of removing large molecular 
substances than hemodialysis (Daugirdas, et al, 2006). By referencing to hemofiltration, a 
dilution-filtration system is developed recently for removing CPAs (Zhou et al, 2011). The 
closed system helps to avoid contamination to cells, and the continuous and automatic 
process could provide particular advantage in efficiency especially for large-scale samples. 
The related research work is introduced in the following. 
2.3 Materials and methods 
Technical Design 
A dilution-filtration system is developed as shown in Fig.16 (Hemofilter: Plasmflo TM AP-
05H/L, ASAHI; Pumps: 400F/M1, Watson-Marlow; silicone tubing: 985-75, Pall). For 
removing CPAs, thawed cell suspension is first transferred into the special blood bag (made by 
an infusion bag). Then, the suspension is driven by the blood pump to flow circularly among 
the bag, the mixer and the hemofilter. While going through the mixer, the suspension is 
quickly diluted by diluent, and the dilution ratio can be controlled to prevent lysis. In the 
hemofilter, extracellular solution containing CPA is partly ultrafiltrated while cells keep inside. 
Along with the circulation goes on, CPAs in cell suspension can be removed continuously. The 
whole process is conducted automatically in a closed system, and thus it is hopeful for this 
method to reduce human labor as well as the risk of contamination significantly. 
 
Fig. 16. Principle of the dilution-filtration system. Cell suspension is diluted and ultrafiltrated 
during circulating in the system, and then the CPAs inside can be continuously removed. 
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Theory of optimal operation protocol 
Optimal operation protocol is defined here as the processes that minimize the operation 
time (to a final CPA concentration below 10g/L) as well as the osmotic cell volume 
excursion. A theoretical model was developed to predict the optimal operation protocols 
under the given experimental conditions (initial CPA concentration, cell density and total 
volume of cell suspension) and practical constraints. The detailed considerations for this 
procedure are described below. 
Basic Assumptions and Formulation 
The theoretical model of the dilution-filtration system is developed (as shown in Fig.17) 
under the following assumptions: (1) Both intra- and extra-cellular solutions in cell 
suspension consist of water, a permeable CPA (e.g. glycerol) and an impermeable salt (e.g. 
NaCl); (2) Blood bag, hollow fibers and their connecting tubing are filled with cell 
suspension, and cells are uniformly distributed in the suspension; (3) Extracellular solution 
is diluted/filtrated immediately and evenly at the diluting/filtrating point when cell 
suspension circulates in the system; (4) Suspension flow is one dimensional, and the 
convection factors can be neglected. 
 
Fig. 17. Theoretical modeling of the system. A: the overall system, and B: a control volume. 
Based on the assumptions, a governing equation about the mass transfer process can be 
derived by focusing on the extracellular solution: 
 
1
( )
e e
DA S
t A x x
         (19) 
where, A refers to effective mass transfer area, D refers to diffusion coefficient, ϕe refers to 
extracellular solute concentration (in osmolality), and S is the mass source/sink term, 
respectively.  
Source/Sink terms 
The source/sink term can be derived by temporarily ignored the diffusion term: 
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  1e e ee e ew w
e e
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dt dt dt dtV V
      (20) 
where eN  and ewV  are the number of osmoles of solutes and water volume in extracellular 
solution, respectively. The overlines in the equation indicate the given deriving condition. 
The terms of edN  and edV  can be further specified as 
 e e e e
d f c
dN dN dN dN    (21) 
 e e e ew w w w
d f c
dV dV dV dV    (22) 
where the subscripts “d”, “f” and “c” refer to the effects of dilution, filtration and cell 
membrane transport, respectively. According to assumption (2), cell suspension inside the 
system can be equally divided into a finite number of control volumes (CVs), as shown in 
Fig.17B. For each CV, the values of the terms in the right hands of equation [21] and [22] can 
be determined as flows. 
i. Dilution/filtration 
According to assumption (3), when a CV is going through the diluting point, the 
extracellular solution will be diluted immediately. Considering the pure filtration method 
used in the system, it is also assumed that ultrafiltration happens only at a certain location 
(the filtrating point, shown in Fig.17A), and the ultrafiltrate has the same composition as the 
extracellular solution. Thus the values of ew
d
dV , e
d
dN , ew
f
dV and e
f
dN  of each CV can be 
determined as 
 
CV at the diluting point
0 CVs at the other locations
d CV
e
bw
d
Q V
QdV
 
 (23) 
 e e dw
d d
dN dV    (24) 
 
CV at the filtrating point
( )(1 )
0 CVs at the other locations
f CV
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w b d s s
f
Q V
dV Q Q V 
  
 (25) 
 e e ew
f f
dN dV    (26) 
where Qf, Qb and Qd are the flow rates of ultrafiltrate, cell suspension and diluent, ϕd is the 
solute concentration in diluent, es  is the extracellular CPA concentration, sV  is the partial 
molar volume of the CPA, and VCV is the volume of a CV, respectively. 
www.intechopen.com
Prevention of Lethal Osmotic Injury to Cells  
During Addition and Removal of Cryoprotective Agents: Theory and Technology 
 
125 
ii. Transportation across cell membrane 
For the ternary system as considered in the present example, the mass transport across cell 
membrane can be described by the two-parameter formalism [2,3]. The total cell volume is 
the sum of the water, CPA and cell solid volumes: 
 i ic w s cbV V V V    (27) 
where the intracellular CPA volume can be determined as i is s sV = V N . As soon as cell volume 
and intracellular solute concentrations are calculated the values of e
c
dN and ew
c
dV can be 
further determined based on mass conservation: 
 e is c s
c
dN n dN  , 0en
c
dN   (28) 
  e i iw c w c c s
c
dV n dV n dV dV      (29) 
where nc is the number of cells in a CV. 
Numerical Simulation 
With finite volume method, a fully implicit control volume integration of the governing 
equation will result in a finite difference scheme: 
   e e e old eold1 1 k 1 1 k 1 1 , 2, , 1oldk k k p CV k k k k k c CV kka a a S V a a a S V k K                        (30)  
where a is the coefficient and K is the total number of CV in the system. The subscript ‘k’ 
refers to the kth CV in the system and the superscript ‘old’ refers to the previous time level. 
Sc and Sp are the constant portion and gradient of the linearized source term: 
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c e
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dN
S
dtV
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e
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p e
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dtV
   (31) 
The subscript ‘k-1’ and ‘k+1’ in equation (30) refer to the previous and next CVs along the x 
direction, respectively. Noting that the cell suspension flows circularly in the closed system, 
the 1st CV is followed by the Kth one. Thus 
    2 1 1 2 2 1 1 11old e e e old eoldK p CV K K c CVa a a S V a a a S V              (32) 
    1 1 1 1 1 1old e e e old e oldK K p CV K K K K K c CV KKa a a S V a a a S V                (33) 
Here, the removal of glycerol from cryopreserved human red blood cells (RBCs) is discussed 
for an instance. For the ease of discussion, it is further restricted that blood volume keeps 
constant, i.e. ultrafiltrate flow rate keeps equal to diluent flow rate, although the presented 
system and model can adapt to more complicated situations. Besides, the concentration of 
NaCl in diluent and thawed blood are considered to be isotonic (0.29 Osmol/kg·water). In 
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this manner, the basic variables for a simulation consist of the experimental conditions 
(including the initial blood volume ( 0bV ), hematocrit (
0h ), and the concentrations of CPA 
( 0sM ) in extra/intracellular solution) as well as the operation parameters (including the flow 
rates of blood (Qb) and diluent (Qd)). The initial values of the other parameters in the model 
can be determined as 
 0 0 /CV bV V K  (35) 
 0 0( )c iso s s iso cbV V V M V V    (36) 
 0 0 0 0/c CV cn V h V  (37) 
where Viso is the isotonic volume of RBC. When terming the CV at the diluting point (x=0) 
when t=0 as the 1st CV (CV1), the initial location of each CV can be allocated. Then the 
values of edN  and edV for each CV can be calculated according to equations [21]-[31]. By 
alternatively calculating the source terms and solving the linearized governing equation, the 
concentration variation of extra-/intracellular solution as well as the responding cell volume 
excursion can be simulated. A typical process is shown in Fig.18, in which 0bV  = 200ml, 
0h = 
30%, 0sM = 6.28 Osmol/kg·water (approximately 40% w/v), Qb=200ml/min, and Qd= 
25ml/min. 
To quantitatively evaluate the effect of an operation protocol, the maximum cell volume and 
the total time cost (to a final glycerol concentration below 10g/L (Brecher, 2002)) of the 
removing process can be taken as criteria for cell recovery rate and removing efficiency, 
respectively. Then the optimal protocol can be found out by applying different operation 
parameters to the given experimental conditions and comparing the simulated results. 
Hereinafter, the diffusion coefficients of glycerol and NaCl in water were set to be 5.43×10-
10 m2/s and 14.41×10-10 m2/s, respectively (Ternstorm et al, 1996). The parameters about 
the dilution -filtration system and RBC membrane are also specified as listed in Table 4 and 
Table 5. These parameters may be different in various applications and systems. 
 
Sections Inner volume Effective area 
From the outlet of blood bag to the diluting point 5ml 1.25×10-5 m2 
From the diluting point to the filtrating point 5ml 1.25×10-5 m2 
From the filtration point to the outlet of hemofilter 85ml 5×10-4 m2 
From the outlet of hemofilter to the inlet of blood bag 5ml 1.25×10-5 m2 
Blood bag Variable 5×10-3 m2 
Table 4. Structural parameters of the dilution-filtration system used in the calculation 
Surface area of RBC(Ac) 135 ×10-12 m2 a 
Hydraulic permeability of cell membrane (Lp) 1.74 ×10-12 m/Pa/s a 
Isotonic volume of RBC (Viso) 98.3 ×10-18 m3 a 
Solid volume of RBC (Vcb) 0.283 ×Viso a
Glycerol permeability to cell membrane (Ps) 6.61 ×10-8 m/s a 
a From literature (Papanek, 1978); 
Table 5. Membrane parameters of human RBC used in the calculation 
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Fig. 18. Simulated glycerol concentration variation and cell volume excursion in CV1 
(initially at the diluting point) during a dilution-filtration process. 
Experiments 
Venous human blood was collected from healthy, adult blood donors in the Red Cross 
Transfusion Center of Heifei. For each donor, up to 200ml whole blood was collected into 
CPDA-1 anticoagulant solution in PVC plastic bag, and stored for up to 24 hours at 4°C. 
Then it was centrifuged at 1615×g for 4 minutes, and the platelets, leukocytes and plasma 
were removed to produce a hematocrit of 75±5 percent.  
Each of the RBC suspensions was transferred into a 400-ml plastic bag, and then it was 
glycerolized by 57.1% w/v glycerol solution with a volume ratio of 2:1 (glycerol to blood) to 
achieve a final glycerol concentration about 40% (w/v) and a hematocrit of 25%-30%. 
Subsequently the blood bag was covered by PE foam sheet (thickness: 5mm) and then placed 
into a metal box (size: 200mm×150mm×20mm). After 30 minutes of equilibrium, the metal box 
was transferred to a -80°C freezer (MDF-U52V, SANYON, Japan) and the RBC suspension was 
frozen gradually. After cryopreservation in the freezer for 2~7 days, the RBC suspension was 
taken out and thawed in a 37°C water bath for about 10 minutes with gentle agitating.  
Each unit of the thawed blood was deglycerolized with the dilution-filtration system as shown 
in Fig. 16, and the operation protocol was theoretically optimized. A typical experimental 
conditions ( 0bV  = 200ml, 
0h = 30%, 0sM = 6.28 Osmol/kg·water) was studied first to reveal the 
general law. To evaluate the effect of each operation parameter, different protocols were 
applied respectively. Fig.19 shows that time cost is significantly reduced but maximum cell 
volume grows directly along with diluent flow rate increases, i.e. the washing efficiency can be 
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improved by applying higher diluent flow rate but more hemolysis may be induced. Thus the 
diluent flow rate has to be carefully selected to achieve the optimal result. Comparatively, the 
effect of blood flow rate is not so complicated. Increasing of blood flow rate has little effect on 
glycerol clearance, but helps to reduce the maximum cell volume excursion.  
 
Fig. 19. Variations of time cost (real line and left Y-axis) and maximum cell volume (dash 
line and right Y-axis) with blood or diluent flow rates as parameters. 
On the other hand, the effect of the operation parameters is also highly related to the blood 
conditions, especially the glycerol concentration. As shown in Fig.20, the same operation 
protocol (Qb=200 ml/min and Qd =20ml/min) is applied to several different conditions, in 
which 0bV  =200ml, 
0h =30%, and 0sM varies from 0.56 Osmol/kg·water (5% w/v) to 6.28 
Osmol/kg·water (40% w/v). When the glycerol concentration decreases, both the glycerol 
clearance and the maximum cell volume are reduced (glycerol clearance is defined here as 
the difference of initial and final numbers of osmoles of glycerol in blood over time cost). 
This phenomenon indicates us that along with the glycerol concentration drops during 
washing, diluent flow rate can be continuously increased to speed up the process without 
inducing extra cell volume excursion. 
Based on the analysis above, it can be concluded that to achieve the optimal 
deglycerolization it is important to: a) use a low diluent flow rate at first, and stepwise 
increase it as CPA concentration drops; b) always use a high blood flow rate. The detailed 
operation parameters of the optimal protocol can be found out by the theoretical model with 
some practical constraints. During the in-vitro experiments, operation protocol for each unit 
was optimized theoretically according to the specific experimental conditions as well as the 
following constraints: maximum cell volume: 1.35 times of the isotonic volume (Viso) of 
RBCs; maximum flow rate of pumps: 200 ml/min and maximum ultrafiltrate flow rate of 
hemofilter: 40 ml/min. The value of upper cell volume level was conservatively selected in 
order to achieve the best cell recovery rate, although the washing efficiency may be limited. 
Samples were taken before and after deglycerolization. Cell count and hematocrit were 
measured by a hematology Analyzer (Ac·T diff II TM, Beckman COULTER®) The Freeze-
Thaw-Wash (FTW) cell count recovery rates were calculated by comparing the total cell counts 
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after thawing to that after washing (Valeri et al, 2001). Residual glycerol concentration in the 
washed blood was measured by a glycerol assay kit (K-GCROL, Megazyme®) and a 
spectrophotometer (756MC UV-VIS, Scientific Instrument®, Shanghai, China). 
 
 
 
 
 
 
 
 
 
Fig. 20. Variations of glycerol clearance (real line and left Y-axis) and maximum cell volume 
(dash line and right Y-axis) with glycerol concentation as a paramter. 
2.4 Results 
A total number of ten units of blood were cryopreserved and deglycerolized by the dilution- 
filtration method, and the results are shown in Table 6. The residual glycerol concentration 
(5.57±2.81 g/L, n=10) is obviously lower than the standard value (10g/L) indicated by 
American association of blood banking (AABB). During the optimization of the operation 
procedures, the maximum cell volume constraints was critically applied (1.35×Viso) for the  
best of cell recovery, and thus the deglycerolizing efficiency is limited. However, each of the 
unit was processed within an hour, which is similar to the automatic centrifuging method 
(Valeri et al, 2001). The cell count recovery rate is 91.19±3.57% (n=10). Comparing to the 
reported methods (Diafiltration method: 70% (Castino et al, 1996), dialysis method, no in 
vitro data was presented (Ding et al, 2007, 2010), manual centrifuging method: >80% 
(Brecher, 2002), and automatic centrifuging method 89.4±3.0% (Valeri et al, 2001)), the 
recovery rate indicates an obviously advantage of our method in cell safety. 
www.intechopen.com
 
Current Frontiers in Cryobiology 
 
130 
UNITS 
Thawed Blood 
Volume (ml) 
Thawed Blood 
Hct (%) 
Cell Count 
Recovery (%) 
Residual 
Glycerol (g/L) 
1 221.8 30 93.64 2.60 
2 204.1 27 85.92 3.39 
3 229.8 29 91.64 12.26 
4 219.0 23 90.91 4.90 
5 217.6 25 91.38 3.39 
6 210.0 28 90.76 6.56 
7 216.7 24 81.60 3.80 
8 200.5 29 94.18 7.34 
9 204.5 21 92.24 5.35 
10 205.0 30 93.80 6.08 
Mean 212.9 27 91.19 5.57 
S.D. 9.49 3 3.57 2.81 
Table 6. In-vitro experiments of deglycerolization with dilution-filtration method 
2.5 Discussion 
An optimized method for addition and removal glycerol from cryopreserved human 
spermatozoa has been illustrated as an example. Although the mechanism(s) of the osmotic 
injury during cryopreservation is not clearly understood, the hypothesis has been tested and 
confirmed, i.e. human sperm volume excursion can be used as an indicator to predict 
possible osmotic injury to spermatozoa during glycerol addition and removal processes. 
Hence, the procedures used for testing the hypothesis provide a methodology to predict 
optimal protocols for cryoprotective agent addition/removal.. 
The FVS, multi-step procedure for the addition of glycerol to human spermatozoa before 
cryopreservation is a conventional, commonly used technique, i.e. ‘drop by drop’ (stepwise) 
addition of a solution with a relatively high glycerol concentration (the volume of each 
‘drop’ is roughly constant) to the spermatozoa or sperm suspension in order to achieve a 
0.6-1.0 M glycerol concentration in the final sperm suspension. In practice, the frozen-
thawed sperm samples containing glycerol are either washed for intrauterine insemination 
or four in-vitro fertilization or directly transferred into the lower female reproductive tract 
for artificial insemination (e.g. intercervical insemination). In both cases, the glycerol is 
abruptly removed from spermatozoa by direct exposure to near isotonic conditions. In the 
example, it was predicted by computer simulation, and confirmed experimentally, that a 
one-step removal of glycerol would cause a high frequency of sperm motility loss even 
without freezing. Based on the results, the FMS removal (≥8 steps) of 1.0 M glycerol is 
recommended. Within the scope of the present investigation, a four-step FMS addition of 
glycerol to spermatozoa to achieve a final 1.0 M glycerol concentration and an eight-step 
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FMS removal of 1.0 M glycerol from spermatozoa were predicted and shown to be 
acceptable procedures which minimize osmotic injury. From calculations, the minimum or 
maximum cell volumes after each step of FVS addition or removal were shown to be 
unequal, some of which may exceed the lower or upper volume limits of the cells. In 
contrast, from calculations, the minimum or maximum cell volumes after each step of FMS 
addition or removal of glycerol were shown to be relatively even (Figures 12 and 13). For a 
fixed number of steps, the minimum or maximum of cell volume excursion during glycerol 
addition or removal using the FMS approach is much smaller than that using the FVS 
approach (see Figures 12 and 13). 
In the example, it was postulated that the sperm osmotic injury as a function of cell 
volume excursion must be determined to predict the optimal glycerol addition and 
removal procedures. However, the definition and determination of ‘sperm injury’ is 
dependent upon the assays used. In the example, sperm motility was used as a standard 
of sperm viability because of its relatively high sensitivity to osmotic changes and the 
requirement of sperm motility for functional viability. If sperm membrane integrity was 
chosen as the endpoint to evaluate the sperm viability, as shown in Figure 7, different 
osmotic tolerance limits would be obtained. One can readily repeat the same procedures 
to predict the extent to which spermolysis is caused by the different glycerol 
addition/removal procedures used in the example, based on the information provided in 
Figure 5. For example, it was found (Figure 7) that >85% of spermatozoa maintained 
membrane integrity when they were returned to isotonic condition after having been 
exposed to anisosmotic conditions ranging from 90 and 700 mOsmol. The corresponding 
sperm volume excursion range was 0.7-2.1 times the isotonic sperm volume (Figure 9). 
From Figures 12 and 13, it can be seen that a one-step addition and one-step removal of 
1.0 M glycerol would result in a minimum relative sperm volume of 0.72 and 
maximum volume of 1.68 respectively, which did not exceed the sperm volume excursion 
range 90.7-2.1 times relative volume) for maintaining >85% sperm membrane integrity. 
Based on this information, one can predict that the majority (>85%) of spermatozoa would 
maintain membrane integrity even using one-step addition and one-step removal of 
glycerol. 
A dilution-filtration system for removing CPAs from cryopreserved cell suspension was 
also introduced here. The system realized continuous processing of cell suspension and the 
dilution & filtration were conducted simultaneously, thus it can achieve much better 
efficiency than traditional multi-step centrifuging methods. Moreover, dilution in the 
system is conducted to cell suspension flow in tubing but not whole suspension in 
container, thus the mixing process should be much rapider and then the osmotic 
disequilibrium during dilution can be significantly reduced.  
A theoretical model was established to simulate the specific process. Based on the model, 
cell volume excursion and the variation of CPA concentration during the dilution-
filtration process can be simulated. Theoretical analysis indicates the operation 
parameters, especially the flow rate of diluent, are critical for the dilution-filtration 
method. In the previous studies concerning removing CPAs with hollow fibers (Castino et 
al, 1996; Arnaud et al 2003; Ding et al, 2007, 2010 ), only the protocols with constant flow 
rates were discussed. However, it was found to be difficult to balance the requirements in 
removing efficiency and cell safety. This problem also exists in the presented dilution-
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filtration method. Removing efficiency can be improved by using higher diluent flow rate, 
but the cell recovery rate may be seriously reduced in the way. Besides, when using a 
constant diluent flow rate, the profile of glycerol concentration is nearly exponential, i.e., 
the removing efficiency starts at the highest value but gradually decreases as the process 
going on. However, when using a stepwise increased diluent flow rate, the removing 
efficiency can be maintained at a high level for a quite long period. Moreover, theoretical 
analysis also indicates stepwise increasing of the diluent flow rate may not cause any 
extra cell damage. Therefore, a stepwise increased diluent flow rate is necessary to 
achieve both high cell recovery rates and efficient glycerol clearance when using the 
dilution-filtration system. In addition, it was also deduced by the theoretical analysis that 
the removing effect of an operation protocol is highly related to the initial volumes and 
cell densities of cell suspensions. Therefore, the optimal operation protocols should be 
specialized and various from case to case. The theoretical model provides an effective tool 
to find out the optimal protocols for given applications. 
The system was also investigated experimentally with deglycerolization from cryopreserved 
blood, and the operation procedures were optimized based on the theoretical model. It is 
clearly indicated by the results that the dilution-filtration method is safe and efficient for 
deglycerolization from cryopreserved RBCs. Comparing to the automatic centrifuging 
method, the cell recovery rate and removing efficiency are similar, but the equipment cost of 
the dilution-filtration system is much lower and thus it can be applied in more areas. We can 
also believe that with properly selected operation parameters, this system can also be 
applied to various CPA removal applications. In addition, all the media are processed in a 
closed system, and thus the system should have further advantages in avoiding 
contamination. It is hopeful for the cells to have a long shelf life after washing. These 
suppositions will be verified by further experiments. 
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